With drug for Parkinson’s approved in US, company reorganizes to create PV and quality divisions that report directly to CEO.
Want to dig deeper into pharmacovigilance and safety?
-
Article
Industry Assessment of the Contribution of Patient Support Programs, Market Research Programs, and Social Media to Patient Safety
Read Now
Jeremy Jokinen et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Podcast
New Ethics and Consent Guidelines Pillars for Safety in India
Listen Now
Srikanth Krishnamurthy, J. Vijay Venkatraman -
Article
Pharmacovigilance in India in Comparison With the US and EU: Challenges and Perspectives
Read Now
Jobin Jose et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
Unlocking the Power of Safety Data with Cloud Technology
Read Now
Brian Longo
Global Forum -
Podcast
Real World Data Expanding into Label Expansion
Listen Now
Nicole Mahoney -
Article
FDA's Sentinel System: Strategies for Expansion and Transformation
Read Now
Gerald Dal Pan, Robert Ball
Global Forum -
Article
Detecting Adverse Drug Events: Accuracy and Generalizability
Read Now
Scott R. Walter et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
Drug Risk Management in China: Key Considerations from Healthcare Professionals
Read Now
Sophia Duan
Global Forum -
Article
21st-Century Oncology Drug Safety via New-Age Regulatory Standards and Practices
Read Now
Peter J. Pitts et al.
Therapeutic Innovation & Regulatory Science
Member-only content
Want to learn more?
Attend our annual Pharmacovigilance & Risk Management Strategies conference in the Americas, or our Pharmacovigilance Strategies Workshop in Europe.